Turning Underutilized Portfolios into Measurable Business Outcomes
Overview
Patents are often treated as defensive assets, yet most portfolios fail to generate tangible financial returns. The gap is not in ownership but in execution: identifying commercially relevant IP, aligning it with market demand, and building strategies that convert protection into revenue.
This seminar in Osaka and Tokyo moves beyond theory to focus on practical, immediately applicable approaches to IP monetization. Participants will gain a clear framework to evaluate their portfolios, identify licensing opportunities, and design strategies that lead to measurable outcomes.
Locations & Dates
📍 Osaka
🗓️ June 2, 2026 | 14:00–16:00
AT Business Center Osaka Umeda, Room 907
(Kanden Real Estate Nishi-Umeda Building)
Capacity: 25 attendees
📍 Tokyo
🗓️ June 5, 2026 | 14:00–16:00
Bitstation Shimbashi
(Shimbashi Station Building No. 1, 6F)
Capacity: 30 attendees
Agenda
14:00 – 14:15 | Welcome & Introduction
Overview of Evalueserve IP & R&D and approach to IP monetization
14:15 – 15:00 | Session 1: Evaluating Monetization Potential
How to identify high-value patents and assess their commercial viability
Frameworks to determine where portfolios can generate revenue
15:00 – 15:15 | Break
15:15 – 16:00 | Session 2: From Opportunity to Execution
Identifying licensing opportunities and selecting target markets
Partner identification and deal strategy fundamentals
Key elements of contracts that drive successful monetization
Key Challenges Addressed
- Patents that do not translate into revenue
- Difficulty demonstrating IP value to leadership
- Unclear licensing opportunities
- Risk of competitor utilization
- Lack of direction on market or partner selection
Experts from Evalueserve
Cheongim Seong
Client Director, Japan Market, Cheongim.Seong@evalueserve.com
Vijay Khatri
Associate Director, Solutions Architect for Licensing Projects
Sara Jeon
Head Of Sales, APAC region, Sara.Jeon@evalueserve.com
Seats are limited and registration is required.
👉 Apply to participate
